Abstract
Coronavirus disease (COVID-19) vaccine can alter the body’s immunological balance leading to autoimmune disease in rare cases. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is one of the autoimmune diseases which have been rarely reported to appear post-COVID-19 vaccine. Herein, we report the case of a 47-year-old woman who developed acute renal failure few days after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine. Corticosteroids along with azathioprine were used for the management.
References
1.
Speiser
DE
, Bachmann
MF
. COVID-19: mechanisms of vaccination and immunity
. Vaccines
. 2020
;8
(3
):404
.2.
Arepally
GM
, Ortel
TL
. Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know
. Blood
. 2021
;138
(4
):293
–8
.3.
Kim
HW
, Jenista
ER
, Wendell
DC
, Azevedo
CF
, Campbell
MJ
, Darty
SN
, . Patients with acute myocarditis following mRNA COVID-19 Vaccination
. JAMA Cardiol
. 2021
;6
(10
):1196
.4.
Bomback
AS
, Kudose
S
, D’Agati
VD
. De novo and relapsing glomerular diseases after COVID-19 vaccination: what do we know so far
. Am J kidney Dis
. 2021
;78
(4
):477
–80
.5.
Chaudhary
JK
, Yadav
R
, Chaudhary
PK
, Maurya
A
, Kant
N
, Rugaie
OA
, . Insights into COVID-19 vaccine development based on immunogenic structural proteins of SARS-CoV-2, host immune responses, and herd immunity
. Cells
. 2021
;10
(11
):2949
.6.
Toussirot
E
, Bereau
M
. Vaccination and induction of autoimmune diseases
. Inflamm Allergy Drug Targets
. 2016
;14
(2
):94
–8
.7.
Watanabe
T
. Vasculitis following influenza vaccination: a review of the literature
. Curr Rheumatol Rev
. 2017
;13
(3
):188
–96
.8.
Rodriguez
Y
, Novelli
L
, Rojas
M
, De Santis
M
, Acosta-Ampudia
Y
, Monsalve
DM
, . Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
. J Autoimmun
. 2020
;114
:102506
.9.
Baimukhamedov
C
, Makhmudov
S
, Botabekova
A
. Seropositive rheumatoid arthritis after vaccination against SARS-CoV-2 infection
. Int J Rheum Dis
. 2021
;24
(11
):1440
–1
.10.
Tuschen
K
, Brasen
JH
, Schmitz
J
, Vischedyk
M
, Weidemann
A
. Relapse of class V lupus nephritis after vaccination with COVID-19 mRNA vaccine
. Kidney Int
. 2021
;100
(4
):941
–4
.11.
Bostan
E
, Gulseren
D
, Gokoz
O
. New-onset leukocytoclastic vasculitis after COVID-19 vaccine
. Int J Dermatol
. 2021
;60
(10
):1305
–6
.12.
Cohen
SR
, Prussick
L
, Kahn
JS
, Gao
DX
, Radfar
A
, Rosmarin
D
, . Leukocytoclastic vasculitis flare following the COVID-19 vaccine
. Int J Dermatol
. 2021
;60
(8
):1032
–3
.13.
Tagini
F
, Carrel
L
, Fallet
B
, Gachoud
D
, Ribi
C
, Monti
M
, . Behçet’s-like adverse event or inaugural Behçet’s disease after SARS-CoV-2 mRNA-1273 vaccination
. Rheumatology
. 2021
;61
(5
):e112
–3
.14.
Caza
TN
, Cassol
CA
, Messias
N
, Hannoudi
A
, Haun
RS
, Walker
PD
, . Glomerular disease in temporal association with SARS-CoV-2 vaccination: a series of 29 cases
. Kidney360
. 2021
;2
(11
):1770
–80
.15.
Shakoor
MT
, Birkenbach
MP
, Lynch
M
. ANCA-associated vasculitis following pfizer-BioNTech COVID-19 vaccine
. Am J kidney Dis
. 2021
;78
(4
):611
–3
.16.
Dube
GK
, Benvenuto
LJ
, Batal
I
. Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis following the Pfizer-BioNTech COVID-19 vaccine
. Kidney Int Rep
. 2021
;6
(12
):3087
–9
.17.
Hakroush
S
, Tampe
B
. Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and pauci-immune crescentic glomerulonephritis after Pfizer-BioNTech COVID-19 mRNA vaccination
. Front Immunol
. 2021
;12
:762006
.18.
Okuda
S
, Hirooka
Y
, Sugiyama
M
. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis after COVID-19 vaccination
. Vaccines
. 2021
;9
(8
):842
.19.
Obata
S
, Hidaka
S
, Yamano
M
, Yanai
M
, Ishioka
K
, Kobayashi
S
, . MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination
. Clin Kidney J
. 2021
;15
(2
):357
–9
.20.
Shirai
T
, Suzuki
J
, Kuniyoshi
S
, Tanno
Y
, Fujii
H
. Granulomatosis with polyangiitis following Pfizer-BioNTech COVID-19 vaccination
. Mod Rheumatol Case Rep
. 2022
:rxac016
. Online ahead of print. https://doi.org/10.1093/mrcr/rxac016.21.
Stevens
KI
, Frangou
E
, Shin
JI
, Anders
HJ
, Bruchfeld
A
, Schonermarck
U
, . Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from ERA-IWG and EUVAS
. Nephrol Dial Transplant
. 2022
:gfac052
. Online ahead of print. https://doi.org/10.1093/ndt/gfac052.22.
Liakopoulos
V
, Roumeliotis
S
, Papachristou
S
, Papanas
N
. COVID-19 and the kidney: time to take a closer look
. Int Urol Nephrol
. 2021
;54
(5
):1053
–7
.23.
D’Agati
VD
, Kudose
S
, Bomback
AS
, Adamidis
A
, Tartini
A
. Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
. Kidney Int
. 2021
;100
(2
):461
–3
.© 2022 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2022
You do not currently have access to this content.